DEXCOM INC Quarterly Current Income Tax Expense (Benefit) in USD for Q4 2017

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Dexcom Inc annual/quarterly Current Income Tax Expense (Benefit) history and growth rate for Q4 2017.
  • Dexcom Inc Current Income Tax Expense (Benefit) for the quarter ending December 31, 2017 was $1.6M.
  • Dexcom Inc annual Current Income Tax Expense (Benefit) for 2023 was $224M, a 214% increase from 2022.
  • Dexcom Inc annual Current Income Tax Expense (Benefit) for 2022 was $71.2M, a 195% increase from 2021.
  • Dexcom Inc annual Current Income Tax Expense (Benefit) for 2021 was $24.1M, a 177% increase from 2020.
Current Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2017 $1.6M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.